Skip to main content

Find Clinical Trials

Home
Conditions
Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)

Clinical trial condition

Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)

Explore clinical trials studying Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase) trial results

Completed

Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers

NCT01894165

Conditions: Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase), Molybdenum Cofactor Deficiency (MoCD), Molybdenum cofactor deficiency, +1 more
Locations: Parexel Baltimore EPCU Baltimore, Maryland, United States

View Trial Details